Your Messages Inbox
Your Article Summary
See Latest ArticlesRoche Discontinues and Plans to Delist Accutane in the U.S.
Roche, 07/01/09
Hoffmann-La Roche Inc. has notified the U.S. Food and Drug Administration of its intent to immediately discontinue the manufacture and distribution of Accutane, its ground-breaking treatment for severe recalcitrant nodular acne that has not responded to other therapies. This decision is being taken for business reasons during a reevaluation of our product portfolio of medicines that are now available from generic manufacturers, and is not being taken for reasons of safety or efficacy.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Tricare contracts may be re-bid after losing plans protest
American Medical News , 11/25/09
GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09
Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09
Article Search
Sponsor